International Scholarly Research Notices has retracted the article titled “Innovative Therapies against Human Glioblastoma Multiforme” [1]. The article was found to contain a substantial amount of material from previously published articles, including the following sources:

(i) Lefranc F., Facchini V., and Kiss R. (2007): “Proautophagic Drugs: A novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas,” Oncologist 12, 1395–1403, [2] (cited as ).

(ii) Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, and Stegh A, et al.: “Malignant Astrocytic Glioma: Genetics, Biology, and Paths to Treatment,” Genes Dev 2007;21:2683–710,, Genes & Dev. 2007. 21: 2683-2710 [3] (not cited).

(iii) Elisabetta Benedetti: “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors,” PPAR Research, 2010, [4] (cited as ).

(iv) Ryuya Yamanaka: “Cell- and Peptide-Based Immunotherapeutic Approaches for Glioma,” Trends in Molecular Medicine, 2008, [5] (cited as ).

(v) Azizul Haque: “Emerging Role of Combination of All-Trans Retinoic Acid and Interferon-gamma as Chemoimmunotherapy in the Management of Human Glioblastoma,” Neurochemical Research, 11/01/2007, [6] (cited as ).